Section 661.40  Reports

a)         Only collection forms with attached filter paper blood collectors supplied by the Division of Laboratories, Illinois Department of Public Health are to be used in submitting blood specimens for newborn screening.

b)         Any hospital performing the required newborn screening tests in addition to submitting specimens to the Illinois Department of Public Health Laboratory shall comply with all requirements of this Part, and shall notify the Department immediately by telephone whenever testing on an infant indicates that:

1)         phenylalanine levels are abnormal;

2)         T4 determinations are abnormal or TSH determinations are abnormal;

3)         total galactose or galactose-1-phosphate uridyl transferase determinations are abnormal;

4)         17-hydroxyprogesterone determinations are abnormal;

5)         biotinidase enzyme determinations are abnormal;

6)         abnormal hemoglobin patterns are detected;

7)         abnormal amino acid or acylcarnitine patterns have been identified;

8)         abnormal determinations that may indicate cystic fibrosis have been identified;

9)         abnormal determinations that may indicate a lysosomal storage disorder have been identified;

10)         abnormal determinations that may indicate severe combined immunodeficiency or T cell lymphopenia have been identified.

(Source:  Amended at 36 Ill. Reg. 1753, effective January 19, 2012)